Goldberg Ellen's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Jun 6, 2023
- Accession no.
- 0001447362-23-000113
- Filed
- Jun 6, 2023
- Trade date
- Jun 5, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market purchases total $69.0K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Goldberg EllenCIK 0001867100 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 5, 2023 | Common Stock | PPurchaseAcquired | +2,300 | $11.23F1 | +$25,829 | 6,565 | Direct | |
| Jun 5, 2023 | Common Stock | PPurchaseAcquired | +2,500 | $17.27 | +$43,175 | 9,065 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
This transaction was executed in multiple trades at prices ranging from $11.19 to $11.23, inclusive. The price reported above reflects the weighted-average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 1 transaction in Table I.